A new look at treating Alzheimer's disease
Tau proteins, and not necessarily beta-amyloid, may be the key to unlocking a viable treatment.
Alzheimer's disease affects more than five million people, and that number is expected to more than double by 2050. While there is no cure, attention has refocused on what many researchers believe is a major player in Alzheimer's: tau proteins.
"Targeting tau proteins may be one of the best ways to identify Alzheimer's disease early in the process and develop more targeted treatments before the symptoms of the disease become too severe," says Dr. Gad Marshall, assistant professor of neurology at Harvard Medical School.